Johnson & Johnson has over 275 FDA-approved products and generates $85 billion in annual revenue. Yet when we tested it across ChatGPT, Claude, Gemini, and Perplexity, it scored 0% AI visibility. Meanwhile, Teladoc Health — a telehealth platform with no FDA-approved drugs — scored 100% visibility across all four engines.
This isn't an anomaly. After analyzing 45 healthcare brands across pharmaceuticals, biotech, medical devices, health insurance, and supplements, we've discovered a striking disconnect: FDA approval and market dominance don't predict AI recommendation.
The regulatory paradox: Traditional markers of healthcare credibility — FDA approval, clinical trials, market capitalization — have little correlation with AI visibility. The brands AI engines recommend aren't necessarily the ones doctors prescribe or investors value most highly.
Healthcare Brand AI Visibility Scores
Top 10 healthcare brands by AI visibility percentage across all engines
The AI Healthcare Hierarchy
When AI engines discuss healthcare, they don't follow the traditional hierarchy of big pharma → medical devices → supplements. Instead, they've created their own ranking system based on different criteria entirely.
Our analysis reveals four distinct tiers in AI healthcare recommendations:
- Digital Health Leaders (44.3% avg visibility): Teladoc, UnitedHealth Group, and other tech-enabled healthcare services dominate AI recommendations
- Big Pharma Survivors (37.5%): Only select pharmaceutical giants like Pfizer and Merck maintain strong AI presence
- Wellness Wildcards (10.0%): Consumer health and wellness brands struggle for AI attention
- The Invisible Majority (2.8%): Most healthcare brands, including major supplement companies and healthcare AI startups, barely register
Notice what's missing from the top tier: traditional drug development powerhouses.AI engines disagree on many brands, but they're remarkably consistent on this: digital-first healthcare companies outperform traditional pharmaceutical manufacturers.
Engine-by-Engine Comparison for Top Healthcare Brands
Number of mentions across ChatGPT, Claude, Gemini, and Perplexity
Healthcare vs. Other Industries: The Authority Gap
Healthcare brands face a unique challenge in AI search. While their average visibility (16.3%) is comparable to other industries (17.3%), the stakes are fundamentally different. When AI recommends a project management tool incorrectly, productivity suffers. When it misses a healthcare brand, patient outcomes could be affected.
Yet healthcare brands actually perform 43% better at earning primary recommendations when they do get mentioned. This suggests AI engines apply higher standards to healthcare recommendations — they mention fewer brands, but treat those mentions more seriously.
This creates what we call "the healthcare authority gap."Brand sentiment matters more in healthcare than other industries, but getting that first mention is significantly harder.
Healthcare vs Other Industries
Average visibility, sentiment, and primary recommendation rates
The 60% Invisibility Problem
The most shocking finding: 60% of healthcare brands in our dataset scored zero AI visibility. They're completely invisible across all four engines. This includes FDA-approved pharmaceutical companies, established medical device manufacturers, and popular supplement brands.
Compare this to other industries, where only 53% of brands are invisible. Healthcare's higher invisibility rate suggests AI engines apply more stringent filters when discussing health-related topics — likely due to the "Your Money or Your Life" (YMYL) content standards that prioritize authoritative sources.
The YMYL factor: AI engines treat healthcare queries as high-stakes YMYL content, requiring higher authority thresholds. This explains why established brands likeJohnson & Johnson get trapped in "alternative" statusor disappear entirely, while digitally-native health companies that optimize for AI visibility dominate.
AI Role Distribution for Healthcare Brands
How healthcare brands are positioned in AI responses
Healthcare Brand Sentiment Distribution
Sentiment scores across all healthcare brands in our dataset
The FDA Approval Paradox
Here's the data that breaks conventional wisdom: FDA approval shows zero correlation with AI visibility. In fact, some of the most FDA-regulated companies perform worst in AI search, while companies that have never sought FDA approval dominate recommendations.
- Johnson & Johnson: 275+ FDA approvals, $85B revenue, 0% AI visibility
- Eli Lilly: Major diabetes and cancer drugs, 8% AI visibility
- Abbott Labs: Medical devices, diagnostics, 17% AI visibility
- Teladoc Health: No FDA approvals needed, 100% AI visibility
- UnitedHealth: Insurance, not pharma, 58% AI visibility
This suggests AI engines prioritize consumer accessibility and digital presenceover regulatory credentials. A patient can sign up for Teladoc in minutes; they can't access Pfizer's drugs without a prescription. AI engines seem to recommend what users can actually act on immediately.
FDA Approval vs AI Visibility
Market cap (bubble size) vs AI visibility for major healthcare companies
The Digital Health Advantage
Healthcare services and tech companies consistently outperform traditional pharma and medical device companies in AI search. The subcategory breakdown reveals why:
Healthcare Services & Tech (44.3% avg visibility): These companies operate in the digital realm AI engines understand. They have robust websites, clear value propositions, and content optimized for search engines that AI models were trained on.
Pharmaceuticals & Biotech (37.5%): The survivors in this category are household names with massive digital footprints. But notice: even "successful" pharma companies lag behind digital health services.
Supplements & Vitamins (9.2%): Despite having 19 brands in our dataset — more than any other subcategory — supplements perform poorly. AI engines appear skeptical of an industry known for questionable health claims.
This isn't just about perfect AI optimization. It's about fundamental business model differences. Digital health companies operate in AI's native environment; traditional healthcare companies are still translating their offline authority into online visibility.
Healthcare Subcategory Performance
Brand count and average visibility by healthcare subsector
What AI Engines Actually Trust
When AI engines do mention healthcare brands, what sources do they cite? Our analysis of citation patterns reveals AI's healthcare authority hierarchy:
- Medical Journals (35.7%): Peer-reviewed research dominates AI citations
- Government Health Sites (30.2%): FDA.gov, NIH, CDC carry massive weight
- Company Websites (17.5%): But only from established, authoritative brands
- News & Media (11.9%): Health journalism from major publications
- Medical Associations (4.8%): AMA, specialty societies, etc.
Notice what's missing: social media, influencer content, and marketing materials. AI engines applying YMYL standards means they heavily weight authoritative, institutional sources.
The citation strategy: Healthcare brands that optimize for AI need content strategies focused on earning citations in medical journals and getting featured on government health sites, not just SEO and social media marketing.
AI Citation Sources for Healthcare Queries
Types of sources AI engines cite when discussing healthcare brands
Why This Matters More Than You Think
Healthcare AI visibility isn't just a marketing metric — it's becoming a patient access issue. As AI-powered health platforms proliferate and consumers increasingly ask ChatGPT and Claude for health advice, AI invisibility means patient invisibility.
The Patient Journey is Changing
Today's healthcare consumer journey increasingly starts with AI. They ask broad questions ("What are my options for managing diabetes?") before they talk to doctors. If your brand isn't in those initial AI responses, you're not in the consideration set.
The Regulatory-Digital Gap
Healthcare companies optimized for FDA approval aren't optimized for AI approval.The content patternsthat satisfy regulators (clinical trial data, adverse event reporting, prescribing information) don't match what AI engines find compelling (clear value propositions, user testimonials, accessible explanations).
The Trust Transfer Problem
Traditional healthcare authority (medical degrees, FDA approval, clinical trials) doesn't automatically transfer to AI authority. Companies must rebuild trust in AI's native language: structured data, comprehensive content, and digital-first user experiences.
Action Items for Healthcare Brands
1. Audit Your AI Presence Before Your Competitors Do
Check your brand's visibility across all four AI engines. Don't assume FDA approval or market leadership translates to AI visibility.Your competitor might already be number one on ChatGPTwhile you're completely invisible.
2. Optimize for Citations, Not Just Keywords
Healthcare brands need citation-worthy content in medical journals and government databases.AI engines cite peer-reviewed research 3x more often than company marketing materials.
3. Bridge the Regulatory-Digital Gap
Your FDA approval documentation is AI training data, but it's not AI-friendly. Create patient-accessible content that explains your value proposition without regulatory jargon. AI engines prefer clear, direct language over medical complexity.
4. Don't Ignore the Long Tail
While Teladoc dominates general "telehealth" queries, there are thousands of specific health conditions where AI engines haven't settled on preferred recommendations.Target the areas where AI engines still disagree.
5. Monitor Across All Four Engines
Healthcare is too important for partial data. Unlike other industries where you might focus on ChatGPT or Perplexity, healthcare brands need comprehensive AI visibility monitoring across all engines.
Frequently Asked Questions
Which healthcare brands have the highest AI visibility?
Teladoc Health leads with 100% AI visibility, followed by Pfizer Inc. and Merck & Co. at 67% each. Traditional pharma giants like Johnson & Johnson surprisingly have 0% visibility despite FDA approval.
Does FDA approval guarantee AI recommendation?
No. Our data shows no correlation between FDA approval and AI visibility. Johnson & Johnson, Eli Lilly, and other FDA-approved companies score poorly, while telehealth companies like Teladoc dominate AI recommendations.
How do healthcare brands compare to other industries in AI search?
Healthcare brands average 16.3% AI visibility vs 17.3% for other industries. However, healthcare brands are 43% more likely to earn primary recommendation status (33.3% vs 23.3%).
Which AI engine is best for healthcare brand visibility?
All four engines show similar patterns for healthcare brands, with slight variations. Perplexity tends to be most generous with citations to medical sources, while Gemini applies the strictest authority filters.
Why are supplement brands performing poorly in AI search?
Supplements average only 9.2% AI visibility despite having 19 brands in our dataset. AI engines appear to prefer established healthcare services and pharma companies over consumer supplement brands, likely due to YMYL content standards.
What content strategies work for healthcare brand AI visibility?
AI engines heavily cite medical journals (35.7%) and government health sites (30.2%) when discussing healthcare. Brands with strong presence in peer-reviewed literature and official health databases perform better than those relying solely on marketing content.